Commentary on ‘A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS’

Commentary on ‘A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS’ is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/17482960802192324
P698PubMed publication ID18642137

P50authorP Nigel LeighQ64857298
P2093author name stringJeremy M. Shefner
P2860cites workPhase II/III randomized trial of TCH346 in patients with ALSQ28241484
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.Q34584573
A clinical trial of creatine in ALS.Q40469445
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosisQ43569621
A randomized sequential trial of creatine in amyotrophic lateral sclerosisQ44383439
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosisQ44562245
High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.Q45296832
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study GroupQ46133871
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trialQ46886269
P433issue4
P921main subjectamyotrophic lateral sclerosisQ206901
P304page(s)254-256
P577publication date2008-01-01
P1433published inAmyotrophic Lateral Sclerosis and Other Motor Neuron DisordersQ15759048
P1476titleCommentary on ‘A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS’
P478volume9

Reverse relations

cites work (P2860)
Q38260277Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
Q58125397Response to commentary on a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS

Search more.